Zheng, K., Xu, L., Cao, G., Fu, S., Dai, Y., Zhu, C., Fan, X., Yan, X., Da, X., Liu, W., Liu, M., Wang, L., Wang, K., Xing, B., Wang, X. (2026). Genotype-directed targeted therapy combined with HAIC and tislelizumab for microsatellite-stable colorectal cancer liver metastasis refractory to multiple-line systemic therapy (proof-of-concept SALVLIVE trial): An interim analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15545